Ligand Pharmaceuticals (LGND) Business Metrics | Revenue Breakdown & Segment Analysis - Stocknear

Ligand Pharmaceuticals

NASDAQ: LGND · Real-Time Price · USD
167.74
1.20 (0.72%)
At close: Sep 04, 2025, 3:59 PM
168.00
0.16%
After-hours: Sep 04, 2025, 04:14 PM EDT

Teriparatide Injection Revenue

History

Quarter Value Change Growth
Jun 30, 2025 2.3M 1.11M +92.95%
Mar 31, 2025 1.19M n/a n/a
Dec 31, 2024 n/a n/a n/a
Sep 30, 2024 2.38M 273K +12.98%
Jun 30, 2024 2.1M 62K +3.04%
Mar 31, 2024 2.04M n/a n/a
Dec 31, 2023 n/a n/a n/a
Sep 30, 2023 n/a n/a n/a
Jun 30, 2023 n/a n/a n/a
Mar 31, 2023 n/a n/a n/a
Dec 31, 2022 n/a n/a n/a
Sep 30, 2022 n/a n/a n/a
Jun 30, 2022 n/a n/a n/a
Mar 31, 2022 n/a n/a n/a
Dec 31, 2021 n/a n/a n/a
Sep 30, 2021 n/a n/a n/a
Jun 30, 2021 n/a n/a n/a
Mar 31, 2021 n/a n/a n/a
Dec 31, 2020 n/a n/a n/a
Sep 30, 2020 n/a n/a n/a
Jun 30, 2020 n/a n/a n/a
Mar 31, 2020 n/a n/a n/a
Jun 30, 2018 n/a n/a n/a
Mar 31, 2018 n/a n/a n/a